Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
BolA family member 2 pseudogene 2 (BOLA2P2) is annotated as a **pseudogene** in the human genome[4]. Pseudogenes are sequences similar to functional genes but generally lack the ability to encode functional proteins due to mutations, premature stop codons, or frameshifts[2]. BOLA2P2 is related to the BOLA2 gene, which is involved in iron homeostasis, but as a pseudogene, BOLA2P2 typically does not produce a functional protein[4]. Pseudogenes can sometimes have regulatory functions at the gene expression level, such as acting as microRNA decoys or influencing gene conversion events, but no specific mechanistic or therapeutic role has been established for BOLA2P2. Consequently, BOLA2P2 is not considered a therapeutic target[2][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on BolA family member 2 pseudogene 2 (BOLA2P2).